uribel tabs

Generic: methenamine, benzoic acid, phenyl salicylate, methylene blue, and hyoscyamine sulfate

Labeler: mission pharmacal company
NDC Directory HUMAN PRESCRIPTION DRUG UNAPPROVED DRUG OTHER Inactive Finished

Drug Facts

Product Profile

Brand Name uribel tabs
Generic Name methenamine, benzoic acid, phenyl salicylate, methylene blue, and hyoscyamine sulfate
Labeler mission pharmacal company
Dosage Form TABLET, COATED
Routes
ORAL
Active Ingredients

benzoic acid 9 mg/1, hyoscyamine sulfate .12 mg/1, methenamine 81.6 mg/1, methylene blue 10.8 mg/1, phenyl salicylate 36.2 mg/1

Manufacturer
Mission Pharmacal Company

Identifiers & Regulatory

Product NDC 0178-0745
Product ID 0178-0745_47e8083a-60e6-b517-e063-6294a90ac104
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category UNAPPROVED DRUG OTHER
Listing Expiration 2027-12-31
Marketing Start 2023-11-07

Pharmacologic Class

Established (EPC)
nitrogen binding agent [epc]
Mechanism of Action
ammonium ion binding activity [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01780745
Hyphenated Format 0178-0745

Supplemental Identifiers

RxCUI
1037234 2670308
UNII
8SKN0B0MIM F2R8V82B84 J50OIX95QV T42P99266K 28A37T47QO
NUI
N0000175806 N0000175807

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name uribel tabs (source: ndc)
Generic Name methenamine, benzoic acid, phenyl salicylate, methylene blue, and hyoscyamine sulfate (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 9 mg/1
  • .12 mg/1
  • 81.6 mg/1
  • 10.8 mg/1
  • 36.2 mg/1
source: ndc
Packaging
  • 100 TABLET, COATED in 1 BOTTLE (0178-0745-01)
source: ndc

Packages (1)

Ingredients (5)

benzoic acid (9 mg/1) hyoscyamine sulfate (.12 mg/1) methenamine (81.6 mg/1) methylene blue (10.8 mg/1) phenyl salicylate (36.2 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "47e8083a-60e6-b517-e063-6294a90ac104", "openfda": {"nui": ["N0000175806", "N0000175807"], "unii": ["8SKN0B0MIM", "F2R8V82B84", "J50OIX95QV", "T42P99266K", "28A37T47QO"], "rxcui": ["1037234", "2670308"], "spl_set_id": ["09821e01-1135-e75c-e063-6294a90a3451"], "pharm_class_epc": ["Nitrogen Binding Agent [EPC]"], "pharm_class_moa": ["Ammonium Ion Binding Activity [MoA]"], "manufacturer_name": ["Mission Pharmacal Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, COATED in 1 BOTTLE (0178-0745-01)", "package_ndc": "0178-0745-01", "marketing_start_date": "20231107"}], "brand_name": "URIBEL TABS", "product_id": "0178-0745_47e8083a-60e6-b517-e063-6294a90ac104", "dosage_form": "TABLET, COATED", "pharm_class": ["Ammonium Ion Binding Activity [MoA]", "Nitrogen Binding Agent [EPC]", "Oxidation-Reduction Activity [MoA]", "Oxidation-Reduction Agent [EPC]"], "product_ndc": "0178-0745", "generic_name": "Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate", "labeler_name": "Mission Pharmacal Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "URIBEL TABS", "active_ingredients": [{"name": "BENZOIC ACID", "strength": "9 mg/1"}, {"name": "HYOSCYAMINE SULFATE", "strength": ".12 mg/1"}, {"name": "METHENAMINE", "strength": "81.6 mg/1"}, {"name": "METHYLENE BLUE", "strength": "10.8 mg/1"}, {"name": "PHENYL SALICYLATE", "strength": "36.2 mg/1"}], "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20231107", "listing_expiration_date": "20271231"}